Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ACN vs GSK✓SelectedUSD · GSKACN vs GSK performance historyLatest closeAs of-3.40%11/17
Stock and ETF performance explorer

ACN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-22.6%
GSK return
+58.9%
Excess return
-81.5%
Maximum drawdown
-68.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.4%-2.3%-1.1%-2.9%
7D-7.4%-3.0%-4.4%-6.8%
30D+4.2%+0.4%+3.8%+4.1%
3M+41.9%-1.2%+43.1%+42.2%
6M+44.6%+0.9%+43.7%+44.7%
YTD-8.2%+4.0%-12.2%-9.5%
1Y+2.0%+7.3%-5.3%0.0%
3Y-22.6%+57.1%-79.7%-27.2%
All-22.6%+58.9%-81.5%-27.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling